CDKN2B-AS1 and atherosclerosis: In this study, we show that ANRIL overexpression causes atherosclerosis in vivo as transgenic mouse overexpression of full-length ANRIL (NR_003529) increases inflammation and aggravates atherosclerosis under ApoE−/− background (ApoE−/−ANRIL mice).